Spinal cord compression in maroteaux-lamy syndrome: Case report and review of the literature with effects of enzyme replacement therapy

Pediatric Neurosurgery

Volumn 48, Issue 3, 2013, Pages 191-198

  Jurecka, Agnieszka ^a,b   Opoka Winiarska, Violetta ^c   Jurkiewicz, Elzbieta ^a   Marucha, Jolanta ^a   Tylki Szymańska, Anna ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Maroteaux Lamy syndrome; Mucopolysaccharidosis type VI; Myelopathy; Spinal cord compression

Indexed keywords

GALSULFASE; N ACETYLGALACTOSAMINE 4 SULFATASE;

ARTICLE; CASE REPORT; CERVICAL MYELOPATHY; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; ENZYME REPLACEMENT; FEMALE; HOMOZYGOSITY; HUMAN; INDEL MUTATION; LAMINECTOMY; MAROTEAUX LAMY SYNDROME; MEDICAL LITERATURE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; THERAPY EFFECT; VERTEBRAL CANAL STENOSIS;

CHILD; DECOMPRESSION, SURGICAL; ENZYME REPLACEMENT THERAPY; FEMALE; HUMANS; MUCOPOLYSACCHARIDOSIS VI; SPINAL CORD COMPRESSION;

EID: 84875213001     PISSN: 10162291     EISSN: 14230305     Source Type: Journal    
DOI: 10.1159/000345635     Document Type: Article

References (31)

1. Neufeld EF, Muenzer J: The mucopolysaccharidoses; in Scriver CR, Beaudet AL, Sly WS (eds): The Metabolic and Molecular Basis of Inherited Disease. New York, McGraw- Hill, 2001, pp 3421-3452.
2. Golda A, Jurecka A, Tylki-Szymanska A: Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux- Lamy syndrome). Int J Cardiol 2011; 158: 6- 11.
3. Kachur E, Del Maestro R: Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 2000; 47: 223-228, discussion 228-229.
4. Harmatz P, Yu ZF, Giugliani R, Schwartz IV, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Ketteridge D, Hopwood JJ, Plecko B, Steiner R, Whitley CB, Kaplan P, Swiedler SJ, Hardy K, Berger KI, Decker C: Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis 2010; 33: 51-60.
5. Harmatz P, Giugliani R, Schwartz I, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Yu ZF, Wittes J, Berger KI, Newman MS, Lowe AM, Kakkis E, Swiedler SJ: Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 2006; 148: 533-539.
6. Harmatz P, Ketteridge D, Giugliani R, Guffon N, Teles EL, Miranda MC, Yu ZF, Swiedler SJ, Hopwood JJ: Direct comparison of measures of endurance, mobility, and joint function during enzyme replacement therapy of mucopolysaccharidosis VI (Maroteaux- Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics 2005; 115:e681- e689.
7. Harmatz P, Whitley CB, Waber L, Pais R, Steiner R, Plecko B, Kaplan P, Simon J, Butensky E, Hopwood JJ: Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux- Lamy syndrome). J Pediatr 2004; 144: 574-580.
8. Jurecka A, Piotrowska E, Cimbalistiene L, Gusina N, Sobczynska A, Czartoryska B, Czerska K, Ounap K, Wegrzyn G, Tylki-Szymanska A: Molecular analysis of mucopolysaccharidosis type VI in Poland, Belarus, Lithuania and Estonia. Mol Genet Metab 2012; 105: 237-243.
9. Marucha J, Jurecka A, RózdzyńskaŚwiatkowska A, Tylki-Szymańska A: Musculoskeletal manifestations of mucopolysaccharidosis type VI and effects of enzyme replacement therapy. Centr Eur J Med 2012; 7: 154-162.
10. Munoz-Rojas MV, Horovitz DD, Jardim LB, Raymundo M, Llerena JC Jr, de Magalhaes Tde S, Vieira TA, Costa R, Kakkis E, Giugliani R: Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to an MPS VI patient with pachymeningitis cervicalis. Mol Genet Metab 2010; 99: 346-350.
11. Modi M, Singla V, Khandelwal N, Prabhakar S, Duberkar D: Maroteaux-Lamy syndrome (mucopolysaccharidosis VI) presenting as familial myelopathy. Int J Neurosci 2011; 121: 337-340.
12. Horovitz DD, Magalhaes TD, AP EC, Carelli LE, DS ES, de Linhares e Riello AP, Llerena JC Jr: Spinal cord compression in young children with type VI mucopolysaccharidosis. Mol Genet Metab 2011; 104: 295-300.
13. Thorne JA, Javadpour M, Hughes DG, Wraith E, Cowie RA: Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 2001; 48: 849-852, discussion 852-853.
14. Peterson DI, Bacchus H, Seaich L, Kelly TE: Myelopathy associated with Maroteaux-Lamy syndrome. Arch Neurol 1975; 32: 127-129.
15. Wald SL, Schmidek HH: Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 1984; 14: 83-88.
16. Tamaki N, Kojima N, Tanimoto M, Suyama T, Matsumoto S: Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux- Lamy syndrome: report of a case. Neurosurgery 1987; 21: 416-419.
17. Kakkis E, McEntee M, Vogler C, Le S, Levy B, Belichenko P, Mobley W, Dickson P, Hanson S, Passage M: Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Genet Metab 2004; 83: 163-174.
18. Munoz-Rojas MV, Vieira T, Costa R, Fagondes S, John A, Jardim LB, Vedolin LM, Raymundo M, Dickson PI, Kakkis E, Giugliani R: Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A 2008; 146A: 2538-2544.
19. Dickson PI, Hanson S, McEntee MF, Vite CH, Vogler CA, Mlikotic A, Chen AH, Ponder KP, Haskins ME, Tippin BL, Le SQ, Passage MB, Guerra C, Dierenfeld A, Jens J, Snella E, Kan SH, Ellinwood NM: Early versus late treatment of spinal cord compression with longterm intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I. Mol Genet Metab 2010; 101: 115-122.
20. Auclair D, Finnie J, Walkley SU, White J, Nielsen T, Fuller M, Cheng A, O'Neill CA, Hopwood JJ: Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats. Pediatr Res 2012; 71: 39-45.
21. Auclair D, Finnie J, White J, Nielsen T, Fuller M, Kakkis E, Cheng A, O'Neill CA, Hopwood JJ: Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen. Mol Genet Metab 2010; 99: 132-141.
22. Chen A, Dickson P: Intrathecal enzyme replacement therapy to treat spinal cord compression in mucopolysaccharidosis: overview and rationale. J Pediatr Rehab Med 2010; 3: 7-11.
23. Belverud S, Mogilner A, Schulder M: Intrathecal pumps. Neurotherapeutics 2008; 5: 114-122.
24. Calias P, Papisov M, Pan J, Savioli N, Belov V, Huang Y, Lotterhand J, Alessandrini M, Liu N, Fischman AJ, Powell JL, Heartlein MW: CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder. PLoS One 2012; 7:e30341.
25. Ceulemans B, van Rhijn J, Kenis S, Krols R, Laridon A, Van Havenbergh T: Opisthotonus and intrathecal treatment with baclofen (ITB) in children. Eur J Pediatr 2008; 167: 641-645.
26. Varhabhatla NC, Zuo Z: Rising complication rates after intrathecal catheter and pump placement in the pediatric population: analysis of national data between 1997 and 2006. Pain physician 2012; 15: 65-74.
27. Pilz H, von Figura K, Goebel HH: Deficiency of arylsulfatase B in 2 brothers aged 40 and 38 years (Maroteaux-Lamy syndrome, type B). Ann Neurol 1979;6: 315-325.
28. Young R, Kleinman G, Ojemann RG, Kolodny E, Davis K, Halperin J, Zalneraitis E, De- Long GR: Compressive myelopathy in Maroteaux- Lamy syndrome: clinical and pathological findings. Ann Neurol 1980;8: 336-340.
29. Taccone A, Tortori Donati P, Marzoli A, Dell'Acqua A, Gatti R, Leone D: Mucopolysaccharidosis: thickening of dura mater at the craniocervical junction and other CT/ MRI findings. Pediatr Radiol 1993;23:349- 352.
30. Linstedt U, Maier C, Joehnk H, Stephani U: Threatening spinal cord compression during anesthesia in a child with mucopolysaccharidosis VI. Anesthesiology 1994;80:227- 229.
31. Mut M, Cila A, Varli K, Akalan N: Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin Neurol Neurosurg 2005;107: 230-235.